Annual CAPEX
$1.69 M
-$16.81 M-90.89%
December 31, 2024
Summary
- As of February 24, 2025, AGIO annual capital expenditures is $1.69 million, with the most recent change of -$16.81 million (-90.89%) on December 31, 2024.
- During the last 3 years, AGIO annual CAPEX has fallen by -$4.06 million (-70.65%).
- AGIO annual CAPEX is now -91.64% below its all-time high of $20.16 million, reached on December 31, 2015.
Performance
AGIO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$967.00 K
+$548.00 K+130.79%
December 31, 2024
Summary
- As of February 24, 2025, AGIO quarterly capital expenditures is $967.00 thousand, with the most recent change of +$548.00 thousand (+130.79%) on December 31, 2024.
- Over the past year, AGIO quarterly CAPEX has increased by +$733.00 thousand (+313.25%).
- AGIO quarterly CAPEX is now -94.59% below its all-time high of $17.87 million, reached on September 30, 2023.
Performance
AGIO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$1.69 M
+$733.00 K+77.00%
December 31, 2024
Summary
- As of February 24, 2025, AGIO TTM capital expenditures is $1.69 million, with the most recent change of +$733.00 thousand (+77.00%) on December 31, 2024.
- Over the past year, AGIO TTM CAPEX has dropped by -$16.81 million (-90.89%).
- AGIO TTM CAPEX is now -91.67% below its all-time high of $20.23 million, reached on September 30, 2020.
Performance
AGIO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
AGIO CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -90.9% | +313.3% | -90.9% |
| 3 y3 years | -70.7% | +313.3% | -90.9% |
| 5 y5 years | -86.0% | +313.3% | -90.9% |
AGIO CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -90.9% | at low | -94.6% | >+9999.0% | -90.9% | +208.0% |
| 5 y | 5-year | -90.9% | at low | -94.6% | +4495.4% | -91.7% | +208.0% |
| alltime | all time | -91.6% | +30.2% | -94.6% | +4495.4% | -91.7% | +7923.8% |
Agios Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.69 M(-90.9%) | $967.00 K(+130.8%) | $1.69 M(+77.0%) |
| Sep 2024 | - | $419.00 K(+165.2%) | $952.00 K(-94.8%) |
| Jun 2024 | - | $158.00 K(+12.1%) | $18.40 M(+0.9%) |
| Mar 2024 | - | $141.00 K(-39.7%) | $18.24 M(-1.4%) |
| Dec 2023 | $18.50 M(+279.0%) | $234.00 K(-98.7%) | $18.50 M(+0.7%) |
| Sep 2023 | - | $17.87 M(<-9900.0%) | $18.38 M(+3259.8%) |
| Jun 2023 | - | -$3000.00(-100.8%) | $547.00 K(-77.9%) |
| Mar 2023 | - | $399.00 K(+253.1%) | $2.48 M(-49.3%) |
| Dec 2022 | $4.88 M(-15.0%) | $113.00 K(+197.4%) | $4.88 M(-47.3%) |
| Sep 2022 | - | $38.00 K(-98.0%) | $9.27 M(+0.7%) |
| Jun 2022 | - | $1.93 M(-31.3%) | $9.21 M(+22.3%) |
| Mar 2022 | - | $2.80 M(-37.7%) | $7.53 M(+31.2%) |
| Dec 2021 | $5.74 M(-59.3%) | $4.50 M(<-9900.0%) | $5.74 M(+218.8%) |
| Sep 2021 | - | -$22.00 K(-108.8%) | $1.80 M(-74.4%) |
| Jun 2021 | - | $249.00 K(-75.4%) | $7.03 M(-35.7%) |
| Mar 2021 | - | $1.01 M(+80.1%) | $10.92 M(-22.6%) |
| Dec 2020 | $14.11 M(+17.3%) | $562.00 K(-89.2%) | $14.11 M(-30.3%) |
| Sep 2020 | - | $5.20 M(+25.6%) | $20.23 M(+18.6%) |
| Jun 2020 | - | $4.14 M(-1.2%) | $17.06 M(+20.3%) |
| Mar 2020 | - | $4.20 M(-37.2%) | $14.19 M(+17.9%) |
| Dec 2019 | $12.03 M(+72.2%) | $6.68 M(+227.8%) | $12.03 M(+87.9%) |
| Sep 2019 | - | $2.04 M(+60.3%) | $6.40 M(-14.7%) |
| Jun 2019 | - | $1.27 M(-37.6%) | $7.50 M(-1.2%) |
| Mar 2019 | - | $2.04 M(+93.5%) | $7.59 M(+8.7%) |
| Dec 2018 | $6.99 M | $1.05 M(-66.5%) | $6.99 M(-3.1%) |
| Sep 2018 | - | $3.14 M(+130.7%) | $7.21 M(+18.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $1.36 M(-5.0%) | $6.09 M(+5.7%) |
| Mar 2018 | - | $1.43 M(+11.9%) | $5.77 M(+24.6%) |
| Dec 2017 | $4.63 M(-53.3%) | $1.28 M(-36.6%) | $4.63 M(+1.3%) |
| Sep 2017 | - | $2.02 M(+95.1%) | $4.57 M(-23.5%) |
| Jun 2017 | - | $1.03 M(+253.2%) | $5.98 M(-22.1%) |
| Mar 2017 | - | $293.00 K(-76.0%) | $7.67 M(-22.6%) |
| Dec 2016 | $9.91 M(-50.8%) | $1.22 M(-64.3%) | $9.91 M(-8.9%) |
| Sep 2016 | - | $3.43 M(+25.3%) | $10.88 M(+1.2%) |
| Jun 2016 | - | $2.73 M(+7.9%) | $10.75 M(-43.1%) |
| Mar 2016 | - | $2.53 M(+15.9%) | $18.90 M(-6.3%) |
| Dec 2015 | $20.16 M(+809.9%) | $2.19 M(-33.7%) | $20.16 M(+3.6%) |
| Sep 2015 | - | $3.30 M(-69.7%) | $19.47 M(+15.9%) |
| Jun 2015 | - | $10.88 M(+186.6%) | $16.80 M(+179.9%) |
| Mar 2015 | - | $3.80 M(+155.0%) | $6.00 M(+170.8%) |
| Dec 2014 | $2.22 M(+71.3%) | $1.49 M(+137.1%) | $2.22 M(+134.2%) |
| Sep 2014 | - | $628.00 K(+630.2%) | $946.00 K(+126.9%) |
| Jun 2014 | - | $86.00 K(+561.5%) | $417.00 K(-59.6%) |
| Mar 2014 | - | $13.00 K(-94.1%) | $1.03 M(-20.2%) |
| Dec 2013 | $1.29 M(-12.3%) | $219.00 K(+121.2%) | $1.29 M(+17.5%) |
| Sep 2013 | - | $99.00 K(-85.9%) | $1.10 M(-48.6%) |
| Jun 2013 | - | $701.00 K(+154.9%) | $2.14 M(+23.9%) |
| Mar 2013 | - | $275.00 K(+957.7%) | $1.73 M(+17.2%) |
| Dec 2012 | $1.48 M(-22.6%) | $26.00 K(-97.7%) | $1.48 M(+1.8%) |
| Sep 2012 | - | $1.14 M(+297.6%) | $1.45 M(+370.5%) |
| Jun 2012 | - | $287.00 K(+1266.7%) | $308.00 K(+1366.7%) |
| Mar 2012 | - | $21.00 K | $21.00 K |
| Dec 2011 | $1.91 M | - | - |
FAQ
- What is Agios Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual CAPEX year-on-year change?
- What is Agios Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Agios Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM CAPEX year-on-year change?
What is Agios Pharmaceuticals annual capital expenditures?
The current annual CAPEX of AGIO is $1.69 M
What is the all time high annual CAPEX for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual capital expenditures is $20.16 M
What is Agios Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, AGIO annual capital expenditures has changed by -$16.81 M (-90.89%)
What is Agios Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of AGIO is $967.00 K
What is the all time high quarterly CAPEX for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly capital expenditures is $17.87 M
What is Agios Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, AGIO quarterly capital expenditures has changed by +$733.00 K (+313.25%)
What is Agios Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of AGIO is $1.69 M
What is the all time high TTM CAPEX for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM capital expenditures is $20.23 M
What is Agios Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, AGIO TTM capital expenditures has changed by -$16.81 M (-90.89%)